Linked e-resources
Details
Table of Contents
Part I Introduction
1. Global strategy for influenza viral infection: What is the latest Information from WHO?
Part II Definition, Epidemiology, and Pathogenesis
2. Epidemiology of influenza with a description of recent trends in Japan: What are the key epidemiologic features of seasonal influenza in terms of time, place, person, and virus (overall and in Japan)?
3. Transmission of influenza virus in the home: How are they transmitted in the home?
4. Cellular and biochemical pathogenic processes in severe influenza virus infection: How does cytokine storm plays a role?
5. Pathology of severe influenza virus pneumonia: what is the importance of alveolar mouths?
6. Pathology, Diagnosis, and Treatment of Influenza Infections/Pneumonia: What are the mechanisms of secondary bacterial pneumonia?
Part III Diagnosis
7. Rapid diagnosis of influenza viral infection: What are the rapid diagnostic tests and molecular diagnosis?
8. Differential diagnosis between influenza and other respiratory viral infections: What are the differential diagnoses?
9. Radiologic findings of influenza pneumonia: What are the recent radiological findings?
10. Oral findings of influenza viral infection: What are the characteristic pharyngeal findings of influenza?
Part IV Complication
11. Classification of pneumonia complicated with influenza viral infection: What are the patterns of pneumonia?
12. Influenza encephalopathy: What is encephalopathy?
Part V Management
13. Treatment guidelines for influenza virus infection: What does the recent guideline state?
14. Treatment strategy for influenza viral infection in adolescent: what is the current adolescent treatment?
15. How to use anti-influenza drugs: zanamivir and oseltamivir
16. How to use anti-influenza drugs: laninamivir octanoate
17. How to use anti-influenza drugs: baloxavir marboxil
18. How to use anti-influenza drugs: peramivir
19. Prophylaxis of influenza viral transmission: What is the current prophylaxis?
Part VI Topics
20. Influenza vaccine efficacy/effectiveness: with special reference to current epidemiological methodology
21. The new anti-influenza drug baloxavir marboxil: Can influenza viruses with reduced susceptibility to baloxavir maintain viral fitness?
22. Viruses resistant to oseltamivir or baloxavir: What do the data reveal about resistance?
1. Global strategy for influenza viral infection: What is the latest Information from WHO?
Part II Definition, Epidemiology, and Pathogenesis
2. Epidemiology of influenza with a description of recent trends in Japan: What are the key epidemiologic features of seasonal influenza in terms of time, place, person, and virus (overall and in Japan)?
3. Transmission of influenza virus in the home: How are they transmitted in the home?
4. Cellular and biochemical pathogenic processes in severe influenza virus infection: How does cytokine storm plays a role?
5. Pathology of severe influenza virus pneumonia: what is the importance of alveolar mouths?
6. Pathology, Diagnosis, and Treatment of Influenza Infections/Pneumonia: What are the mechanisms of secondary bacterial pneumonia?
Part III Diagnosis
7. Rapid diagnosis of influenza viral infection: What are the rapid diagnostic tests and molecular diagnosis?
8. Differential diagnosis between influenza and other respiratory viral infections: What are the differential diagnoses?
9. Radiologic findings of influenza pneumonia: What are the recent radiological findings?
10. Oral findings of influenza viral infection: What are the characteristic pharyngeal findings of influenza?
Part IV Complication
11. Classification of pneumonia complicated with influenza viral infection: What are the patterns of pneumonia?
12. Influenza encephalopathy: What is encephalopathy?
Part V Management
13. Treatment guidelines for influenza virus infection: What does the recent guideline state?
14. Treatment strategy for influenza viral infection in adolescent: what is the current adolescent treatment?
15. How to use anti-influenza drugs: zanamivir and oseltamivir
16. How to use anti-influenza drugs: laninamivir octanoate
17. How to use anti-influenza drugs: baloxavir marboxil
18. How to use anti-influenza drugs: peramivir
19. Prophylaxis of influenza viral transmission: What is the current prophylaxis?
Part VI Topics
20. Influenza vaccine efficacy/effectiveness: with special reference to current epidemiological methodology
21. The new anti-influenza drug baloxavir marboxil: Can influenza viruses with reduced susceptibility to baloxavir maintain viral fitness?
22. Viruses resistant to oseltamivir or baloxavir: What do the data reveal about resistance?